Orphazyme A/S ORPH

Orphazyme A/S Total Non Current Liabilities 2011-2026 | ORPH

Annual Total Non Current Liabilities Orphazyme A/S

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
35.3 M	61.8 M	105 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
61.8 M	105 K	32.4 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 4.55	-0.66 %	$ 10.9 B	Australia
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Compugen Ltd. CGEN	31.3 M	$ 2.59	-5.31 %	$ 242 M	Israel
I-Mab IMAB	131 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.91	3.25 %	$ 6.69 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 22.57	-0.44 %	$ 3.74 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Evogene Ltd. EVGN	5.36 M	$ 0.78	-0.66 %	$ 27.9 M	Israel
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Fennec Pharmaceuticals FENC	24.6 M	$ 6.33	-5.52 %	$ 181 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Galapagos NV GLPG	2.41 B	$ 27.94	-1.69 %	$ 2.69 B	Belgium
Genmab A/S GMAB	769 M	$ 26.19	-2.24 %	$ 16 B	Danmark
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	341 M	$ 100.7	-1.33 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Innoviva INVA	377 M	$ 23.2	-2.08 %	$ 1.56 B	USA
Innate Pharma S.A. IPHA	105 M	$ 1.45	3.57 %	$ 235 M	France
Inventiva S.A. IVA	13.8 M	$ 4.93	-1.5 %	$ 138 M	France
Aquestive Therapeutics AQST	90.3 M	$ 4.06	-0.73 %	$ 434 M	USA
Jaguar Health JAGX	10.3 M	$ 0.23	-5.44 %	$ 536 K	USA
Arcutis Biotherapeutics ARQT	167 M	$ 22.63	-2.86 %	$ 2.88 B	USA
KalVista Pharmaceuticals KALV	5.05 M	$ 26.73	38.9 %	$ 1.44 B	Britain
Autolus Therapeutics plc AUTL	50.6 M	$ 1.42	-4.39 %	$ 378 M	Britain
Kamada Ltd. KMDA	7.06 M	$ 8.14	-0.09 %	$ 260 M	Israel
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.95	1.37 %	$ 4.86 M	Israel